Sample preparation optimization in fecal metabolic profiling

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1047, Issue , 2017, Pages 115-123

  Deda, Olga ^a   Chatziioannou, Anastasia Chrysovalantou ^a   Fasoula, Stella ^a   Palachanis, Dimitris ^a   Raikos, Νicolaos ^a   Theodoridis, Georgios A ^a   Gika, Helen G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Extraction optimization; Feces; Metabolic profiling; Metabolomics; Sample preparation

Indexed keywords

BIOMOLECULES; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EXTRACTION OPTIMIZATIONS; FECES; METABOLIC PROFILING; METABOLOMICS; SAMPLE PREPARATION;

EXTRACTION;

ACETONITRILE; ADENOSINE; AMINO ACID; ATROLACTIC ACID; BIOGENIC AMINE; CARBOHYDRATE; CREATINE; CYTIDINE; FUMARIC ACID; GLUCOSE; GUANINE; HYDROXYBUTYRIC ACID; INOSINE; MALIC ACID; MALONIC ACID; METHANOL; ORGANIC SOLVENT; ORNITHINE; PROPANOL; PURINE; TAURINE; THIAMINE; TRYPTAMINE; TYROSINE; URIDINE; VITAMIN; XANTHINE;

ARTICLE; CONTROLLED STUDY; EXTRACTION; FECES ANALYSIS; FEMALE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; TANDEM MASS SPECTROMETRY; VOLUME; ANIMAL; CHEMISTRY; FECES; LIQUID CHROMATOGRAPHY; METABOLOME; PROCEDURES; SPECIMEN HANDLING; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, LIQUID; FECES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; RATS; RATS, WISTAR; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY;

EID: 84979500071     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.06.047     Document Type: Article

References (54)

1. [1] Xu, J., Gordon, J.I., Honor thy symbionts. Proc. Natl. Acad. Sci. 100 (2003), 10452–10459, 10.1073/pnas.1734063100.
2. [2] Guinane, C.M., Cotter, P.D., Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 6 (2013), 295–308, 10.1177/1756283X13482996.
3. [3] Kamada, N., Chen, G.Y., Inohara, N., Núñez, G., Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14 (2013), 685–690, 10.1038/ni.2608.
4. [4] Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease. Nature 474 (2011), 307–317, 10.1038/nature10209.
5. [5] Musso, G., Gambino, R., Cassader, M., Obesity, diabetes, and gut microbiota the hygiene hypothesis expanded?. Diabetes Care 33 (2010), 2277–2284, 10.2337/dc10-0556.
6. [6] DiBaise, J.K., Frank, D.N., Mathur, R., Impact of the gut microbiota on the development of obesity: current concepts. Am. J. Gastroenterol.(Suppl. 1), 2012, 22–27, 10.1038/ajgsup.2012.5.
7. [7] Blaut, M., Klaus, S., Intestinal microbiota and obesity. Handb. Exp. Pharmacol., 2012, 251–273, 10.1007/978-3-642-24716-3_11.
8. [8] Cani, R., Bibiloni, C., Knauf, A., Waget, A.M., Neyrinck, N.M., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481, 10.2337/db07-1403.
9. [9] Larsen, N., Vogensen, F.K., van den Berg, F.W.J., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., Sørensen, S.J., Hansen, L.H., Jakobsen, M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085, 10.1371/journal.pone.0009085.
10. [10] DuPont, A.W., DuPont, H.L., The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol. 8 (2011), 523–531, 10.1038/nrgastro.2011.133.
11. [11] Danese, S., Fiocchi, C., Etiopathogenesis of inflammatory bowel diseases. World J. Gastroenterol. WJG 12 (2006), 4807–4812.
12. [12] Cho, J.H., The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8 (2008), 458–466, 10.1038/nri2340.
13. [13] Maloy, K.J., Powrie, F., Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474 (2011), 298–306, 10.1038/nature10208.
14. [14] Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625, 10.1038/nature07008.
15. [15] Frank, D.N., Amand, A.L.S., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. 104 (2007), 13780–13785, 10.1073/pnas.0706625104.
16. [16] Sartor, R.B., Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008), 577–594, 10.1053/j.gastro.2007.11.059.
17. [17] Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., Klimešová, K., Přibylová, J., Bártová, J., Sanchez, D., Fundová, P., Borovská, D., Šrůtková, D., Zídek, Z., Schwarzer, M., Drastich, P., Funda, D.P., The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8 (2011), 110–120, 10.1038/cmi.2010.67.
18. [18] Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E.V., La Scola, B., Raoult, D., Microbial culturomics: paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 18 (2012), 1185–1193, 10.1111/1469-0691.12023.
19. [19] Hayashi, H., Sakamoto, M., Benno, Y., Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol. Immunol. 46 (2002), 535–548, 10.1111/j.1348-0421.2002.tb02731.x.
20. [20] Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023, 10.1038/4441022a.
21. [21] Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G.R., Collins, M.D., Doré, J., Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65 (1999), 4799–4807.
22. [22] De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D.I., Cristofori, F., Guerzoni, M.E., Gobbetti, M., Francavilla, R., Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One, 8, 2013, e76993, 10.1371/journal.pone.0076993.
23. [23] De Preter, V., Verbeke, K., Metabolomics as a diagnostic tool in gastroenterology. World J. Gastrointest. Pharmacol. Ther. 4 (2013), 97–107, 10.4292/wjgpt.v4.i4.97.
24. [24] van Rheenen, P.F., de Vijver, E.V., Fidler, V., Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ, 341, 2010, c3369, 10.1136/bmj.c3369.
25. [25] Lehmann, F.S., Burri, E., Beglinger, C., The role and utility of faecal markers in inflammatory bowel disease. Ther. Adv. Gastroenterol., 2014, 10.1177/1756283X14553384.
26. [26] Le Gall, G., Noor, S.O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I.T., Colquhoun, I.J., Kemsley, E.K., Narbad, A., Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J. Proteome Res. 10 (2011), 4208–4218, 10.1021/pr2003598.
27. [27] Monleón, D., Morales, J.M., Barrasa, A., López, J.A., Vázquez, C., Celda, B., Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 22 (2009), 342–348, 10.1002/nbm.1345.
28. [28] Marchesi, J.R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I.D., Wang, Y., Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6 (2007), 546–551, 10.1021/pr060470d.
29. [29] Bjerrum, J.T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Günther, U., Nielsen, O.H., Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics, 2014, 1–12, 10.1007/s11306-014-0677-3.
30. [30] Weir, T.L., Manter, D.K., Sheflin, A.M., Barnett, B.A., Heuberger, A.L., Ryan, E.P., Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One, 8, 2013, e70803, 10.1371/journal.pone.0070803.
31. [31] Ponnusamy, K., Choi, J.N., Kim, J., Lee, S.-Y., Lee, C.H., Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J. Med. Microbiol. 60 (2011), 817–827, 10.1099/jmm.0.028126-0.
32. [32] Goedert, J.J., Sampson, J.N., Moore, S.C., Xiao, Q., Xiong, X., Hayes, R.B., Ahn, J., Shi, J., Sinha, R., Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 35 (2014), 2089–2096, 10.1093/carcin/bgu131.
33. [33] Marcobal, A., Kashyap, P.C., Nelson, T.A., Aronov, P.A., Donia, M.S., Spormann, A., Fischbach, M.A., Sonnenburg, J.L., A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 7 (2013), 1933–1943, 10.1038/ismej.2013.89.
34. [34] Huang, H., Zhang, A., Cao, H., Lu, H., Wang, B., Xie, Q., Xu, W., Li, L.-J., Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. Dig. Liver Dis. 45 (2013), 677–682, 10.1016/j.dld.2013.01.001.
35. [35] W. Hou, D. Zhong, P. Zhang, Y. Li, M. Lin, G. Liu, M. Yao, Q. Liao, Z. Xie, A strategy for the targeted metabolomics analysis of 11 gut microbiota-host co-metabolites in rat serum, urine and feces by ultra performance liquid chromatography–tandem mass spectrometry, J. Chromatogr. A. (n.d.), doi: 10.1016/j.chroma.2015.12.031.
36. [36] Bezabeh, T., Somorjai, R.L., Smith, I.C.P., MR metabolomics of fecal extracts: applications in the study of bowel diseases. Magn. Reson. Chem. 47 (2009), S54–S61, 10.1002/mrc.2530.
37. [37] Deda, O., Gika, H.G., Wilson, I.D., Theodoridis, G.A., An overview of fecal sample preparation for global metabolic profiling. J. Pharm. Biomed. Anal. 113 (2015), 137–150, 10.1016/j.jpba.2015.02.006.
38. [38] Bollard, M.E., Stanley, E.G., Lindon, J.C., Nicholson, J.K., Holmes, E., NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18 (2005), 143–162, 10.1002/nbm.935.
39. [39] Theodoridis, G., Gika, H., Franceschi, P., Caputi, L., Arapitsas, P., Scholz, M., Masuero, D., Wehrens, R., Vrhovsek, U., Mattivi, F., LC–MS based global metabolite profiling of grapes: solvent extraction protocol optimisation. Metabolomics 8 (2012), 175–185, 10.1007/s11306-011-0298-z.
40. [40] Michopoulos, F., Gika, H., Palachanis, D., Theodoridis, G., Wilson, I.D., Solid phase extraction methodology for UPLC–MS based metabolic profiling of urine samples. Electrophoresis, 2015, 10.1002/elps.201500101.
41. [41] Lamichhane, S., Yde, C.C., Schmedes, M.S., Jensen, H.M., Meier, S., Bertram, H.C., Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Anal. Chem. 87 (2015), 5930–5937, 10.1021/acs.analchem.5b00977.
42. [42] Wu, J., An, Y., Yao, J., Wang, Y., Tang, H., An optimised sample preparation method for NMR-based faecal metabonomic analysis. Analyst 135 (2010), 1023–1030, 10.1039/B927543F.
43. [43] Saric, J., Wang, Y., Li, J., Coen, M., Utzinger, J., Marchesi, J.R., Keiser, J., Veselkov, K., Lindon, J.C., Nicholson, J.K., Holmes, E., Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res. 7 (2008), 352–360, 10.1021/pr070340k.
44. [44] Gao, X., Pujos-Guillot, E., Martin, J.-F., Galan, P., Juste, C., Jia, W., Sebedio, J.-L., Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal. Biochem. 393 (2009), 163–175, 10.1016/j.ab.2009.06.036.
45. [45] Gao, X., Pujos-Guillot, E., Sébédio, J.-L., Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal. Chem. 82 (2010), 6447–6456, 10.1021/ac1006552.
46. [46] Ng, J.S.Y., Ryan, U., Trengove, R.D., Maker, G.L., Development of an untargeted metabolomics method for the analysis of human faecal samples using cryptosporidium-infected samples. Mol. Biochem. Parasitol. 185 (2012), 145–150, 10.1016/j.molbiopara.2012.08.006.
47. [47] Phua, L.C., Koh, P.K., Cheah, P.Y., Ho, H.K., Chan, E.C.Y., Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 937 (2013), 103–113, 10.1016/j.jchromb.2013.08.025.
48. [48] Mayor, R.S.A., Optimisation of sample preparation for direct SPME-GC–MS analysis of murine and human faecal volatile organic compounds for metabolomic studies. J. Anal. Bioanal. Tech., 5, 2014, 10.4172/2155-9872.1000184.
49. [49] Pechlivanis, A., Chatziioannou, A.C., Veskoukis, A.S., Kouretas, D., Mougios, V., Theodoridis, G.A., GC–MS analysis of blood for the metabonomic investigation of the effects of physical exercise and allopurinol administration on rats. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 966 (2014), 127–131, 10.1016/j.jchromb.2014.02.005.
50. [50] Virgiliou, C., Sampsonidis, I., Gika, H.G., Raikos, N., Theodoridis, G.A., Development and validation of a HILIC-MS/MS multitargeted method for metabolomics applications. Electrophoresis 36 (2015), 2215–2225, 10.1002/elps.201500208.
51. [51] Smith, C.A., Want, E.J., O'Maille, G., Abagyan, R., Siuzdak, G., XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 78 (2006), 779–787, 10.1021/ac051437y.
52. [52] Romick-Rosendale, L.E., Goodpaster, A.M., Hanwright, P.J., Patel, N.B., Wheeler, E.T., Chona, D.L., Kennedy, M.A., NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn. Reson. Chem. 47 (2009), S36–S46, 10.1002/mrc.2511.
53. [53] Hong, Y.-S., Ahn, Y.-T., Park, J.-C., Lee, J.-H., Lee, H., Huh, C.-S., Kim, D.-H., Ryu, D.H., Hwang, G.-S., 1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model. Arch. Pharm. Res. 33 (2010), 1091–1101, 10.1007/s12272-010-0716-1.
54. [54] Calvani, R., Brasili, E., Praticò, G., Capuani, G., Tomassini, A., Marini, F., Sciubba, F., Finamore, A., Roselli, M., Marzetti, E., Miccheli, A., Fecal and urinary NMR-based metabolomics unveil an aging signature in mice. Exp. Gerontol. 49 (2014), 5–11, 10.1016/j.exger.2013.10.010.